Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

被引：0
|
作者：
Arjun Bhadhuri
Daniel Dröschel
Mike Guldimann
Claudia Jetschgo
Judit Banhazi
Matthias Schwenkglenks
C. Simone Sutherland
机构：
[1] Institute of Pharmaceutical Medicine (ECPM),
[2] University of Basel,undefined
[3] Novartis Pharma Schweiz AG,undefined
[4] Novartis Pharma AG,undefined
来源：
BMC Health Services Research | / 22卷
关键词：
RPE65; Cost effectiveness; Health Economics; Inherited retinal disease; Voretigene neparvovec; Switzerland;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Daniel Viriato
    Natalie Bennett
    Raisa Sidhu
    Elizabeth Hancock
    Hannah Lomax
    David Trueman
    Robert E. MacLaren
    Advances in Therapy, 2020, 37 : 1233 - 1247
  • [22] Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice
    Testa, Francesco
    Bacci, Giacomo
    Falsini, Benedetto
    Iarossi, Giancarlo
    Melillo, Paolo
    Mucciolo, Dario Pasquale
    Murro, Vittoria
    Salvetti, Anna Paola
    Sodi, Andrea
    Staurenghi, Giovanni
    Simonelli, Francesca
    EYE, 2024, 38 (13) : 2504 - 2515
  • [23] Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
    Maguire, Albert M.
    Russell, Stephen
    Wellman, Jennifer A.
    Chung, Daniel C.
    Yu, Zi-Fan
    Tillman, Amy
    Wittes, Janet
    Pappas, Julie
    Elci, Okan
    Marshall, Kathleen A.
    McCague, Sarah
    Reichert, Hannah
    Davis, Maria
    Simonelli, Francesca
    Leroy, Bart P.
    Wright, J. Fraser
    High, Katherine A.
    Bennett, Jean
    OPHTHALMOLOGY, 2019, 126 (09) : 1273 - 1285
  • [24] Impact of Voretigene Neparvovec on Legal Blindness in Germany in Patients with RPE65 Mutation-Associated Inherited Retinal Dystrophy - Post Hoc Analysis of Phase III Trial Data
    Lacey, Sue
    Aouadj, Celia
    Chung, Daniel C.
    Reape, Kathleen Z.
    High, Katherine A.
    Viriato, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] Five-Year Post-Injection Results of the Phase 3 Trial of Voretigene Neparvovec-rzyl in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease
    Bennett, Jean
    Russell, Stephen R.
    High, Katherine A.
    Drack, Arlene V.
    Yu, Zi-Fan
    Chung, Daniel C.
    Reape, Kathy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [26] Chromatic pupillometry as an objective outcome to evaluate effects of Voretigene Neparvovec treatment in patients with RPE65-related inherited retinal dystrophies
    Testa, Francesco
    Melillo, Paolo
    Di Iorio, Valentina
    Citro, Amelia
    Rossi, Settimio
    Della Corte, MIchele
    Simonelli, Francesca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [27] Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
    Testa, Francesco
    Melillo, Paolo
    Di Iorio, Valentina
    Iovino, Claudio
    Farinaro, Francesco
    Karali, Marianthi
    Banfi, Sandro
    Rossi, Settimio
    Della Corte, Michele
    Simonelli, Francesca
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
    Francesco Testa
    Paolo Melillo
    Valentina Di Iorio
    Claudio Iovino
    Francesco Farinaro
    Marianthi Karali
    Sandro Banfi
    Settimio Rossi
    Michele Della Corte
    Francesca Simonelli
    Scientific Reports, 12
  • [29] BUDGET IMPACT AND THE COST-EFFECTIVENESS OF INTRODUCING VORETIGENE NEPARVOVEC FOR TREATING INHERITED RETINAL DISEASES IN THE KINGDOM OF SAUDI ARABIA
    Al Jedai, A.
    AL-Mudaiheem, H.
    Ba-Abbad, R.
    Alsulaiman, S.
    Amro, S. A. A.
    Awad, N.
    Ojeil, R.
    VALUE IN HEALTH, 2024, 27 (12) : S100 - S100
  • [30] Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease
    Russell, Stephen R.
    Bennett, Jean
    Wellman, Jennifer A.
    Chung, Daniel C.
    High, Katherine A.
    Yu, Zi-Fan
    Tillman, Amy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345